Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

News > Portugal & Spain

Find below news from the Portugal and Spain. Listed are news about these countries as well as from organisations located there.

Total search results: 395 | Ordered by Source (descending)
1 2 3 4  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
[iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2018-10-31
Zeltia S.A.. (9/15/15). "Press Release: PharmaMar Opens New Affiliate in UK". Madrid. 2015-09-15
Zeltia S.A.. (9/1/15). "Press Release: Pharmaceutical Council Recommends Approval of Yondelis (trabectedin) in Japan". Madrid. 2015-09-01
Zeltia S.A.. (8/20/15). "Press Release: PharmaMar Announces License Agreement with Specialised Therapeutics Australia Pty for Aplidin (plitidepsin) in Oncology". Madrid. 2015-08-20
Zeltia S.A.. (7/31/15). "Press Release: PharmaMar Passes the U.S. FDA Manufacturing Inspection for Yondelis Active Ingredient". Madrid. 2015-07-31
Zeltia S.A.. (7/28/15). "Press Release: Grupo Zeltia Reports First Half 2015 Financial Results". Madrid. 2015-07-28
Zeltia S.A.. (7/23/15). "Press Release: PharmaMar Announces License Agreement with TTY Biopharm for Aplidin (plitidepsin) in Hematological Cancers". Madrid. 2015-07-23
Zeltia S.A.. (7/23/14). "Press Release: PharmaMar Initiates a Phase I Study with Aplidin in Combination with Bortezomib and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma". Madrid. 2014-07-23
Zeltia S.A.. (7/23/12). "Press Release: Report at 30 June 2012. 1H12 Highlights". Madrid. 2012-07-23
Zeltia S.A.. (7/22/15). "Press Release: Genomica and the Foundation for Excellence and Quality in Oncology Announce a Framework Agreement for Collaboration in Oncology". Madrid. 2015-07-22
Zeltia S.A.. (7/2/12). "Press Release: Zeltia Announces that Subsidiary PharmaMar Is Commencing a Phase II Trial with PM01183 in Patients with Breast Cancer". Madrid. 2012-07-02
Zeltia S.A.. (7/17/14). "Press Release: Sylentis Receives Authorisation to Commence Phase IIb Clinical Trial with Bamosiran (SYL040012) for Treating Ocular Hypertension Associated with Glaucoma". Madrid. 2014-07-17
Zeltia S.A.. (6/29/15). "Press Release: PharmaMar Initiates the Phase III Study CORAIL for the Anticancer Agent PM1183 in Patients with Platinum-resistant Ovarian Cancer". Madrid. 2015-06-29
Zeltia S.A.. (6/29/12). "Press Release: Zeltia Receives 9.5 Million Euro from the Spanish Public Administrations for the Payment of Outstanding Invoices". Madrid. 2012-06-29
Zeltia S.A.. (2/3/15). "Press Release: U.S. FDA Grants Priority Review to Yondelis NDA for Advanced Soft-tissue Sarcoma". Madrid. 2015-02-03
Zeltia S.A.. (2/28/14). "Press Release: Zeltia Net Profit Soars 72%. Reported EBITDA of 23.8 Million Euros Increased by 16.6%". Madrid. 2014-02-28
Zeltia S.A.. (2/28/13). "Press Release: Zeltia Posts Net Attributable Profit of €6.6 Million (+39%)". Madrid. 2013-02-28
Zeltia S.A.. (2/27/13). "Press Release: Zeltia Announces that Subsidiary Sylentis Has Commenced Phase II Clinical Trials with Compound SYL1001 for Treating Eye Discomfort Associated with Dry Eye Syndrome". Madrid. 2013-02-27
Zeltia S.A.. (2/26/15). "Press Release: Zeltia's Board of Directors Will Propose to the Next Shareholders' Meeting that Pharma Mar Merge with and Absorb Its Parent Company, Zeltia. The Board of Directors Will also Request that Pharma Mar Seek an IPO in 2015-02-26
Zeltia S.A.. (2/26/15). "Press Release: Grupo Zeltia Net Attributable Profit Amounted to 13 Million Euro in 2014 (+16%). Group Total Revenues Amounted to 178 Million Euro (+8%).". Madrid. 2015-02-26
Zeltia S.A.. (12/2/14). "Press Release: Zeltia Announces that Its Board of Directors Has Approved a Strategy to Explore Merging PharmaMar and Zeltia in Advance of a Listing Request in the US". Madrid. 2014-12-02
Zeltia S.A.. (11/7/12). "Press Release: PharmaMar Germany Commences Commercial Activity". Madrid. 2012-11-07
Zeltia S.A.. (11/25/14). "Press Release: PharmaMar Announces that Its Partner Janssen Has Submitted a New Drug Application for Yondelis to the U.S. FDA for the Treatment of Advanced Soft Tissue Sarcoma". Madrid. 2014-11-25
Zeltia S.A.. (11/20/14). "Press Release: PharmaMar Results for Antitumoral Compounds and Their Mechanism of Action at EORTC-NCI-AACR Emphasize an Innovative Pipeline of Targeted Ttherapies". Barcelona. 2014-11-20
Zeltia S.A.. (10/25/12). "Press Release: Zeltia Group Operating Revenues up 7%". Madrid. 2012-10-25
Zeltia S.A.. (1/22/13). "Press Release: Genomica AB Starts Its Commercial Activity". Madrid. 2013-01-22
Zeltia S.A.. (1/13/15). "Press Release: PharmaMar Will Start a Phase III Study of PM1183 in Combination with Doxorubicin in Relapsed SCLC". Madrid. 2015-01-13
Ysios Capital. (9/24/18). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Guillem Laporta as Principal and Two New Venture Partners". Barcelona. 2018-09-24
Ysios Capital. (3/19/14). "Press Release: Ysios Capital Begins Fundraising for Ysios Biofund II. New Fund to Back Disruptive Life Sciences Company in Europe and US". Barcelona. 2014-03-19
Ysios Capital. (10/18/16). "Press Release: Ysios Capital Raises €126,4 m ($140 m) for Its Second Fund, Ysios Biofund II Innvierte". Barcelona. 2016-10-18
Ysios Capital Partners. (12/01/2011). "Press Release: Ysios Capital Partners and “la Caixa” Lead MedLumics €3.5million/$4.7million Series A Financing". Madrid. 2011-12-01
Ysios Capital Partners. (09/28/2009). "Press Release: Laia Crespo Joins Ysios Capital Partners as Investment Manager". Barcelona. 2009-09-28
Ysios Capital Partners. (09/21/2010). "Press Release: Ysios Capital Partners Leads €5million Series A Financing of Sabirmedical". Barcelona. 2010-09-21
Ysios Capital Partners. (09/13/2011). "Press Release: Ysios Capital Partners Leads €29.2million Series D Financing of AM-Pharma". Barcelona. 2011-09-13
Ysios Capital Partners. (09/02/2009). "Press Release: Ysios Capital Partners Participates in the $36million . €25million Series B Financing of Endosense". Barcelona. 2009-09-02
Ysios Capital Partners. (05/29/2012). "Press Release: Cristina Garmendia Returns to Ysios Capital as Partner". Barcelona. 2012-05-29
Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. 2017-11-15
Wilex AG. (11/21/11). "Press Release: Wilex AG. ARISER Independent Data Monitoring Committee (IDMC) Recommends Conducting the Final Analysis of the Pivotal Phase III Trial with Rencarex". Munich. 2011-11-21
VCN Biosciences SL. (7/9/12). "Press Release: Grifols Acquires 40% of the Capital of Biotechnology Firm VCN Bioscience. The Group’s Investment Will Ensure the Viability of Research Projects in the Field of Oncology". Barcelona. 2012-07-09
Vall d’Hebron Institute of Oncology (VHIO). (6/10/15). "Press Release: Vall d’Hebron Institute of Oncology and AstraZeneca Form an Oncology Alliance". 2015-06-10
Universität Stuttgart. (12/10/12). "Pressemitteilung: Uni Stuttgart und Oncomatrix starten Forschungskooperation. Neue Krebsmedikamente für die Behandlung metastasierender Tumore". 2012-12-10
TomTec Imaging Systems GmbH. (8/25/09). "Press Release: TomTec Launches the Vascular Analysis Solution M’Ath. TomTec Extends CardioArena Product Portfolio with a Vascular Analysis Solution". Barcelona. 2009-08-25
TiGenix N.V.. (8/23/12). "Press Release: TiGenix Financial Half-year Results 2012". 2012-08-23
TiGenix N.V.. (7/30/15). "Press Release: TiGenix Expands Pipeline and Enters the Cardiology Field with Clinical-stage Company Acquisition". Leuven. 2015-07-30
TiGenix N.V.. (2/25/11). "Press Release: TiGenix Announces Proposed Combination with Cellerix. Presentation – Creating the European Cell Therapy Leader". Leuven & Tres Cantos. 2011-02-25
TiGenix N.V.. (2/25/11). "Press Release: TiGenix Announces Proposed Combination with Cellerix and Capital Increase through a Public Rights Offering. Combination Will Create the European Cell Therapy Leader with Two Marketed Products and a Promising Pipel 2011-02-25
TiGenix N.V.. (11/22/13). "Press Release: TiGenix Completes EUR 12 Million Capital Increase with Strategic Investor Grifols". Leuven. 2013-11-22
Thermo Fisher Scientific Inc.. (9/3/14). "Press Release: Thermo Fisher Scientific Teams with National Reference Labs on New European Regulation, Allowing GC-MS/MS to Confirm Dioxins in Feed and Food". 2014-09-03
Thermo Fisher Scientific Inc.. (12/15/15). "Press Release: Thermo Fisher Scientific Awards 2015 Attune NxT Flow Cytometry Grant to California Cancer Researcher". Albany, NY. 2015-12-15
Thermo Fisher Scientific Inc.. (11/19/13). "Press Release: Leading EU and UK Pesticide Testing Labs Collaborate with Thermo Fisher Scientific". Runcorn. 2013-11-19
Symphogen A/S. (3/7/11). "Press Release: Symphogen Receives US Patent on Lead Cancer Compound Sym004. Sym004 Anti-cancer Activity Highlighted at Major Oncology Meeting". Paris. 2011-03-07
Sygnis Pharma AG. (8/14/12). "Press Release: Sygnis Announces Three Months Results for Fiscal Year 2012/2013". Heidelberg. 2012-08-14
Sygnis Pharma AG. (7/25/12). "Press Release: Sygnis Reports Financial Results for Fiscal Year 2011/12. Strategic Realignment Successfully Initiated". Heidelberg. 2012-07-25
Sygnis Pharma AG. (7/18/12). "Press Release: Sygnis and Genetrix Announce Proposed Combination of Businesses of Sygnis and Genetrix’ Subsidiary X-Pol". Heidelberg. 2012-07-18
Sygnis Pharma AG. (4/30/13). "Press Release: Sygnis Reports Financial Results for Fiscal Year 2012". Heidelberg. 2013-04-30
Sygnis Pharma AG. (3/25/13). "Press Release: Sygnis Announces Management Board Changes (Ad hoc-Release)". Heidelberg & Madrid. 2013-03-25
Sygnis Pharma AG. (12/6/12). "Press Release: Sygnis Announces Completion of the X-Pol Biotech Acquisition. Registration of the Transaction and the Previous Capital Reduction (Ratio 8:1) in the Commercial Register". Heidelberg. 2012-12-06
Sygnis Pharma AG. (12/20/12). "Press Release: Sygnis Announces the Adaptation of Its Organisation to the New Business Activity". Heidelberg. 2012-12-20
Sygnis Pharma AG. (11/14/12). "Press Release: Sygnis Announces Six Months Results of Fiscal Year 2012". Heidelberg. 2012-11-14
Sygnis Pharma AG. (10/18/12). "Press Release: Annual General Meeting of Sygnis Pharma AG Approves Combination of Businesses with X-Pol Biotech. Comprehensive Strategic Realignment Agreed – Election of New Supervisory Board". Heidelberg. 2012-10-18
Sygnis AG. (5/13/15). "Press Release: Sygnis AG Announces Genetrix S.L. Has Taken Over All Shares from Genetrix Life Sciences AB to Become New Majority Shareholder". Madrid & Heidelberg. 2015-05-13
Sygnis AG. (11/17/15). "Press Release: Sygnis AG Plans to Issue New Shares to Finance further Growth and Commercialization of Proprietary Product Portfolio [Not for US, CA, JP and AU] NOT FOR DISTRIBUTION, PUBLICATION, OR TRANSMISSION IN USA, CANADA, 2015-11-17
Sygnis AG. (10/27/16). "Press Release: Sygnis AG to Receive €1.9 Million Non-dilutive R&D Funding from the Spanish Government". Madrid & Heidelberg. 2016-10-27
Sygnis AG. (01/21/15). "Press Release: Sygnis Signs Distribution Agreement with BioNova Cientifica, for its Innovative TruePrime Single Cell WGA Kit in Spain". Madrid. 2015-01-21
STAT-Diagnostica & Innovation S.L.. (5/6/13). "Press Release: Medical Diagnostics Company STAT-Diagnostica Secures 22.1 Million USD / 17 Million Euros in Series B Financing". Barcelona. 2013-05-06
STAT-Diagnostica & Innovation S.L.. (4/11/16). "Press Release: STAT-Diagnostica Announces 25 Million Euros in Series C Financing Led by Gilde Healthcare. Funding Will Be Used to Accelerate Go-to-Market Strategy". Barcelona. 2016-04-11
Stat Diagnostica. (05/06/2013). "Press Release: Medical Diagnostics Company STAT-Diagnostica Secures 22.1 Million USD/17 Million Euros in Series B Financing". Barcelona. 2013-05-06
SpectralWorks Ltd.. (8/15/17). "Press Release: SpectralWorks and Mestrelab Research SL Announce Mutual Reseller Agreement". 2017-08-15
Sophia Genetics S.A.. (9/25/15). "Press Release: Welcome to Our 11 New Partners !". 2015-09-25
Sophia Genetics S.A.. (7/29/15). "Press Release: Game Changing Partnership between Sophia Genetics and Genycell Biotech to Dramatically Expand Patients’ Access to Genetic Diagnosis in the Iberian Peninsula". Lausanne. 2015-07-29
Sophia Genetics S.A.. (7/16/15). "Press Release: Cutting Edge Spanish Genetic Laboratories Join Data Driven Medicine European Movement". Lausanne. 2015-07-16
Signature Diagnostics AG. (7/8/10). "Press Release: Signature Diagnostics Presents Positive Colorectal Screening Study Results at the 12th World Congress on Gastrointestinal Cancer in Barcelona". Potsdam. 2010-07-08
Signature Diagnostics AG. (10/27/10). "Press Release: Signature Diagnostics to Present Company’s Blood-based Colorectal Cancer Screening Strategy at the 18th UEGW Congress in Barcelona. Advantages of Detector C and Dectector C/Plus in Early Detection of 2010-10-27
SGS S.A.. (12/9/16). "Press Release: SGS Acquires 70 Percent Stake in Biopremier, Portugal". 2016-12-09
Servier. (10/5/15). "Press Release: Servier Offers Its Expertise in Industrial R&D, Chemical Synthesis and Pharmaceutical Manufacturing to Partners". 2015-10-05
Selexis S.A.. (10/10/16). "Press Release: Selexis SA Announces Participation at Two Upcoming Industry Conferences". Geneva. 2016-10-10
Scienion AG. (2/4/13). "Press Release: Scienion’s sciFlexarrayer Used for Cantilever Biosensor Production of Madrid-based Bionanomechanics Lab in Collaboration with Mecwins". Dortmund & Berlin. 2013-02-04
Scienion AG. (11/5/12). "Press Release: Joint Technologies – Scienion and Genomica Expand Collaboration to Provide Innovative Printing Technology for Multiple Applications. Companies Jointly Present at Medica, November 14–17, 2012, in Düsseldorf". Berlin 2012-11-05
Scienion AG. (10/29/14). "Press Release: Collaboration between Scienion and Genomica Results in a Novel Multiplex Based Detection Kit for the Identification and Specific Differentiation of 18 Microorganisms Causing Sexual Transmitted Infections (STIs)". 2014-10-29
Sabirmedical. (5/10/11). "Press Release: Dr. Oriol de Solà-Morales Joins Sabirmedical’s Management Team". Barcelona. 2011-05-10
Royal Philips Electronics. (5/31/10). "Press Release: New Clinical Study Shows Telehealth Patients Experience a Significant Improvement in Care and Quality of Life". Berlin. 2010-05-31
Roche. (9/17/14). "Press Release: Roche to Present Latest Oncology Advances during ESMO 2014 Congress". Basel. 2014-09-17
Roche. (7/8/09). "Press Release: The Research Institute of the Hospital Universitari Vall d’Hebron Is the First Spanish Health Centre to Acquire High-performance Sequencing Technology of 454 Life Sciences". Barcelona. 2009-07-08
Roche. (4/7/14). "Press Release: Roche and Oryzon Announce Collaboration to Develop Epigenetics-based Medicines". Basel & Barcelona. 2014-04-07
Roche. (4/2/09). "Press Release: 454 Sequencing Boosts Genomics Research in Spain. Genome Sequencer FLX Installed at University of Barcelona". Barcelona. 2009-04-02
Roche. (11/24/09). "Press Release: Roche and the Department of Health of Junta de Andalucía Collaborate in Spanish Medical Genome Project". Penzberg. 2009-11-24
Recordati Industria Chimica e Farmaceutica S.p.A.. (9/9/13). "Press Release: Recordati Acquires Spanish Pharmaceutical Company Laboratorios Casen Fleet". Milan. 2013-09-09
Recordati Industria Chimica e Farmaceutica S.p.A.. (10/21/13). "Press Release: Recordati Finalizes Its Acquisition of Laboratorios Casen Fleet in Spain". Milan. 2013-10-21
Qlucore AB. (1/14/13). "Press Release: Qlucore Targets Academic and Commercial Biotech, Life Sciences Markets with Novo Newton Scientific. New Alliance Increases Qlucore’s Sales and Marketing Presence in Ireland, Spain, Italy and South Africa". 2013-01-14
Qiagen N.V.. (5/19/16). "Press Release: Qiagen Bioinformatics Continues to Set the Standard with Hereditary Disease Solution. Expanded Offering Provides Highly Accurate Clinical Sequence Data Interpretation". Barcelona. 2016-05-19
Qiagen N.V.. (4/19/18). "Press Release: Qiagen Announces European Launch of QIAstat-Dx, a Next Generation Platform for Syndromic Insights". Hilden & Germantown, MD. 2018-04-19
Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. 2018-01-31
Proteros Biostructures GmbH. (9/22/11). "Press Release: Almirall Enters into Integrated Discovery Agreement with Proteros". Barcelona. 2009-11-22
Probiodrug AG. (3/8/11). "Press Release: Probiodrug and Its Collaborators Will Present Novel Insights into the Pathophysiology of AD and Biomarkers at AP/PD 2011 in Barcelona". Halle (Saale). 2011-03-08
Philips. (6/2/09). "Press Release: Sant Pau Hospital and Philips Pioneer Healthcare Technology Partnership Model. 10-year Agreement Will Provide Barcelona Hospital with Consistent Access to Leading Imaging Technology Solutions, Designed Around Its Needs" 2009-06-02
Phenomenex, Inc.. (5/2/18). "Press Release: Phenomenex Expands International Network with Direct Sales to Portugal". Torrance, CA. 2018-05-02
Phenomenex, Inc.. (5/1/15). "Press Release: Phenomenex Acquires Micron Analitica S.A. in Spain to Expand Global Presence". Torrance, CA. 2015-05-01
Pharming Group N.V.. (8/29/11). "Press Release: Pharming Grants SOBI Additional Territories for the Commercialisation of Ruconest". Leiden. 2011-08-29
PharmaMar S.A.. (9/22/16). "Press Release: PharmaMar Submits MAA to EMA for Aplidin for the Treatment of Multiple Myeloma". Madrid. 2016-09-22
PharmaMar S.A.. (8/2/16). "Press Release: PharmaMar Initiates a Pivotal Phase III ATLANTIS Study with PM1183 in Combination with Doxorubicin in Patients with Small Cell Lung Cancer". Madrid. 2016-08-02
1 2 3 4  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 600x60px

» top